0000899243-22-027419.txt : 20220802 0000899243-22-027419.hdr.sgml : 20220802 20220802173624 ACCESSION NUMBER: 0000899243-22-027419 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220731 FILED AS OF DATE: 20220802 DATE AS OF CHANGE: 20220802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHROFF ZUBEEN CENTRAL INDEX KEY: 0001056630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36415 FILM NUMBER: 221130073 MAIL ADDRESS: STREET 1: C/O HALSEY DRUG CO INC STREET 2: 1827 PACIFIC STREET CITY: BROOKLYN STATE: NY ZIP: 11233 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quotient Ltd CENTRAL INDEX KEY: 0001596946 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 264719797 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA BUSINESS PHONE: 41274832286 MAIL ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-31 0 0001596946 Quotient Ltd QTNT 0001056630 SHROFF ZUBEEN C/O GALEN PARTNERS, 680 WASHINGTON BLVD STAMFORD CT 06901 1 0 0 0 Ordinary Shares 11995740 I See footnote Ordinary Shares 2022-07-31 4 M 0 13538 A 131999 D Ordinary Shares Option (Right to buy) 11.62 2025-10-31 Ordinary Shares 7505 7505 D Ordinary Shares Option (Right to buy) 8.00 2024-04-29 Ordinary Shares 5000 5000 D Ordinary Shares Option (Right to buy) 9.95 2024-10-31 Ordinary Shares 5025 5025 D Ordinary Shares Option (Right to buy) 5.73 2026-10-31 Ordinary Shares 8726 8726 D Ordinary Shares Option (Right to buy) 5.21 2027-10-31 Ordinary Shares 9597 9597 D Ordinary Shares Option (Right to buy) 6.41 2028-10-31 Ordinary Shares 6240 6240 D Ordinary Shares Option (Right to buy) 7.78 2029-10-31 Ordinary Shares 8158 8158 D Ordinary Shares Option (Right to buy) 4.55 2030-10-31 Ordinary Shares 13611 13611 D Restricted Stock Units 2022-07-31 4 M 0 10870 0.00 D Ordinary Shares 10870 10868 D Restricted Stock Units 2022-07-31 4 M 0 2668 0.00 D Ordinary Shares 2668 2668 D Ordinary Shares Option (Right to buy) 2.53 2031-10-31 Ordinary Shares 24040 24040 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. Includes 10,913,091 ordinary shares held of record by Galen V LP, 931,945 ordinary shares held by Galen International V LP, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V LP, Galen International V LP and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. All 7,505 options have vested and remain exercisable. All 5,000 options have vested and remain exercisable. All 5,025 options have vested and remain exercisable. All 8,726 options have vested and remain exercisable. All 9,597 options have vested and remain exercisable. All 6,240 options have vested and remain exercisable. 2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022. All 13,611 options have vested and remain exercisable. On October 31, 2021, the Reporting Person was granted 43,478 restricted stock units, of which 32,574 have vested and have converted into ordinary shares. The remaining 10,868 restricted stock units will vest on October 31, 2022. On October 31, 2021, the Reporting Person was granted 10,672 restricted stock units, of which 8,004 have vested and have converted into ordinary shares. The remaining 2,668 restricted stock units will vest on October 31, 2022. The options vest and become exercisable on October 31, 2022. /s/ Zubeen Shroff 2022-08-02